In the BioHarmony Drug Report Database
Aztreonam
Azactam, Cayston (aztreonam) is a small molecule pharmaceutical. Aztreonam was first approved as Azactam on 1986-12-31. It is used to treat bacterial infections, cellulitis, endometritis, intraabdominal infections, and pseudomonas infections amongst others in the USA. It has been approved in Europe to treat cystic fibrosis and respiratory tract infections. Aztreonam’s patent is valid until 2021-12-20 (FDA).
Trade Name
|
Cayston |
|---|---|
Common Name
|
aztreonam |
ChEMBL ID
|
CHEMBL158 |
Indication
|
bacterial infections, cellulitis, cystic fibrosis, endometritis, intraabdominal infections, pseudomonas infections, respiratory tract infections, urinary tract infections |
Drug Class
|
Image (chem structure or protein)